Vitamins in COVID 19 hospitalized - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias death D28detailed results Zhang, 2020 0.50 [0.17; 1.50]
0.50 [0.17 ; 1.50 ] Zhang, 2020 1 0% 56 NA not evaluable deathsdetailed results COVID-VIT-D, 2022 1.48 [0.75; 2.92]
Entrenas (Pilot Calcifediol), 2020 0.12 [0.01; 2.79]
Jamali Moghadam Siahkali, 2021 1.00 [0.19; 5.40]
Kumari, 2020 0.60 [0.22; 1.64]
Murai, 2020 1.53 [0.53; 4.43]
Zhang, 2020 0.50 [0.17; 1.50]
0.94 [0.57 ; 1.56 ] COVID-VIT-D, 2022, Entrenas (Pilot Calcifediol), 2020, Jamali Moghadam Siahkali, 2021, Kumari, 2020, Murai, 2020, Zhang, 2020 6 19% 1,122 moderate not evaluable deaths (time to event analysis only)detailed results Zhang, 2020 0.50 [0.17; 1.50]
0.50 [0.17 ; 1.50 ] Zhang, 2020 1 0% 56 NA not evaluable clinical deteriorationdetailed results Zhang, 2020 0.87 [0.23; 3.27]
0.87 [0.23 ; 3.27 ] Zhang, 2020 1 0% 56 NA not evaluable hospital dischargedetailed results Murai, 2020 0.99 [0.71; 1.38]
0.99 [0.71 ; 1.38 ] Murai, 2020 1 0% 240 NA not evaluable mechanical ventilationdetailed results Jamali Moghadam Siahkali, 2021 1.30 [0.31; 5.40]
Kumari, 2020 0.76 [0.33; 1.76]
Murai, 2020 0.49 [0.21; 1.14]
0.68 [0.39 ; 1.19 ] Jamali Moghadam Siahkali, 2021, Kumari, 2020, Murai, 2020 3 0% 447 low not evaluable viral clearance detailed results Rastogi, 2020 6.33 [1.54; 26.00]
6.33 [1.54 ; 26.00 ] Rastogi, 2020 1 0% 40 NA not evaluable ICU admissiondetailed results Entrenas (Pilot Calcifediol), 2020 0.03 [0.00; 0.27]
Murai, 2020 0.71 [0.37; 1.37]
0.17 [0.01 ; 3.79 ] Entrenas (Pilot Calcifediol), 2020, Murai, 2020 2 86% 313 moderate not evaluable serious adverse eventsdetailed results Murai, 2020 0.99 [0.02; 50.39]
0.99 [0.02 ; 50.39 ] Murai, 2020 1 0% 237 NA not evaluable adverse eventsdetailed results Murai, 2020 1.99 [0.07; 59.94]
1.99 [0.07 ; 59.94 ] Murai, 2020 1 0% 237 NA not evaluable 0.0 10.0 1.0 relative treatment effect www.metaEvidence.org 2024-05-12 06:28 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
pathologies: 95,94,90,91
- treatments: 1244,523,885,734,1439
- roots T: 290
